Fernández Tussy, Pablo; Rodríguez Agudo, Rubén; Fernández Ramos, David; Barbier Torres, Lucía; Zubiete Franco, Imanol; López de Davalillo, Sergio; Herráez Aguilar, Elisa; Goikoetxea Usandizaga, Naroa; Lachiondo Ortega, Sofía; Simón Espinosa, Jorge; Lopitz Otsoa, Fernando; Gutiérrez de Juan, Virginia; McCain, Misti V.; Perugorria Montiel, María Jesús; Mabe Alvarez, Jon; Navasa, Nicolás; Rodrigues, Cecilia M. P.; Fabregat, Isabel; Boix, Loreto; Sapena, Victor; Anguita Castillo, Juan de Dios; Lu, Shelly C.; Mato, José M.; Bañales Asurmendi, Jesús María ; Villa, Erica; Reeves, Helen L.; Bruix, Jordi; Reig, María; Marín, José J. G.; Cardoso Delgado, Teresa de Jesús; Martínez Chantar, María Luz (Springer Nature, 2021-05-28)
Dysregulation of miRNAs is a hallmark of cancer, modulating oncogenes, tumor suppressors, and drug responsiveness. The multi-kinase inhibitor sorafenib is one of the first-line drugs for advanced hepatocellular carcinoma ...